Quantitative aspects of 32P-postlabeling.
Hemminki
K
K
Institute of Occupational Health, Helsinki, Finland.
Szyfter
K
K
Vodicka
P
P
Koivisto
P
P
Mustonen
R
R
Reunanen
A
A
D002273:Carcinogens / Q000008:administration & dosage / Q000633:toxicity; D004247:DNA / Q000032:analysis* / Q000187:drug effects; D004249:DNA Damage; D003848:Deoxyguanine Nucleotides / Q000032:analysis; D009712:Nucleotides, Cyclic / Q000032:analysis; D010761:Phosphorus Radioisotopes; D011116:Polynucleotide 5'-Hydroxyl-Kinase; D015719:Single-Strand Specific DNA and RNA Endonucleases
D002273:Carcinogens; D003848:Deoxyguanine Nucleotides; D009712:Nucleotides, Cyclic; D010761:Phosphorus Radioisotopes; C007257:2'-deoxyguanosine 5'-phosphate; D004247:DNA; D011116:Polynucleotide 5'-Hydroxyl-Kinase; D015719:Single-Strand Specific DNA and RNA Endonucleases